PedAM
Pediatric Disease Annotations & Medicines
| Disease | artery disease |
| Phenotype | C0022658|kidney disease |
| Sentences | 22 |
| PubMedID- 23551675 | Therapeutic potential of low-density lipoprotein apheresis in the management of peripheral artery disease in patients with chronic kidney disease. |
| PubMedID- 24478035 | Clinical utility of serum cystatin c in predicting coronary artery disease in patients without chronic kidney disease. |
| PubMedID- 20966602 | A recent study showed that statins reduce cardiovascular events in stable coronary artery disease patients with chronic kidney disease (ckd). |
| PubMedID- 22335251 | Prevalence and risk factors for chronic kidney disease in patients with coronary artery disease. |
| PubMedID- 20119930 | Ventricular function and all-cause mortality in chronic kidney disease patients with angiographic coronary artery disease. |
| PubMedID- 24986458 | Previous reports of percutaneous coronary intervention versus coronary artery bypass graft outcomes in coronary artery disease patients with chronic kidney disease (ckd) were inconsistent. |
| PubMedID- 20057157 | Does obesity attenuate the effect of metabolic syndrome on chronic kidney disease in patients with coronary artery disease. |
| PubMedID- 23369274 | We present a review of current strategies for the diagnosis and treatment of coronary artery disease (cad) in patients with advanced chronic kidney disease who are on the waiting list for transplants, based on data from the literature and originated from a single-center cohort of 1,250 patients with maximum follow-up of 12 years. |
| PubMedID- 24241090 | Association between visfatin levels and coronary artery disease in patients with chronic kidney disease. |
| PubMedID- 24043442 | Soluble tweak levels are independently associated with coronary artery disease severity in patients with stage 2-3 kidney disease. |
| PubMedID- 25051258 | Conclusions: chronic kidney disease is common in patients with stable coronary artery disease and is associated with comorbidities. |
| PubMedID- 23269877 | The optimal revascularization therapy for coronary artery disease patients with chronic kidney disease. |
| PubMedID- 25599331 | Rationale: trimethylamine-n-oxide (tmao), a gut microbial-dependent metabolite of dietary choline, phosphatidylcholine (lecithin), and l-carnitine, is elevated in chronic kidney diseases (ckd) and associated with coronary artery disease pathogenesis. |
| PubMedID- 23208015 | Chronic kidney disease (ckd) is associated with increased coronary artery disease (cad) and coronary artery calcification. |
| PubMedID- 20643244 | Short- and long-term outcomes of coronary artery bypass grafting or drug-eluting stent implantation for multivessel coronary artery disease in patients with chronic kidney disease. |
| PubMedID- 20921817 | Plasma cystatin c concentration reflects the severity of coronary artery disease in patients without chronic kidney disease. |
| PubMedID- 24527682 | Coronary artery disease in patients with chronic kidney disease: a clinical update. |
| PubMedID- 23723693 | The ability of nt-probnp to detect chronic heart failure and predict all-cause mortality is higher in elderly chinese coronary artery disease patients with chronic kidney disease. |
| PubMedID- 20886058 | There is a high prevalence of chronic kidney disease (ckd) in patients with coronary artery disease (cad), ranging from 23%–46% in different studies [1–3]. |
| PubMedID- 25869350 | Objectives: the goal of this study was to compare the diagnostic accuracy of the coronary artery calcium score (cacs), coronary computed tomography angiography (cta), single-photon emission computed tomography (spect), and a combination of these tools in the diagnosis of obstructive coronary artery disease (cad) in patients with chronic kidney disease referred for cardiac evaluation before kidney transplantation. |
| PubMedID- 25757535 | Cardiac valve calcification is associated with presence and severity of coronary artery disease in patients with pre-dialysis chronic kidney disease. |
| PubMedID- 24720456 | A high prevalence of atherosclerotic coronary artery disease amongst patients with end-stage kidney disease (eskd) partly explains this exaggerated risk. |
Page: 1